Genzyme Recalls Murky Batches Of Transplant Drug
Genzyme Corp. has voluntarily recalled 100,000 vials of Thymoglobulin, a drug widely used during kidney transplants, even though most of the batches have already been used without any complaints or adverse...To view the full article, register now.
Already a subscriber? Click here to view full article